Vaisala acquires Veriteq

Vaisala Pty Ltd
Friday, 11 June, 2010

Vaisala has strengthened its position in the life science market through the strategic acquisition of Veriteq Instruments Inc, a continuous monitoring system and data logger company based in Canada.

Veriteq is a provider of productised continuous monitoring systems and data logger solutions for the life science industry comprising pharmaceutical, biotechnological and medical device companies.

Life science is a focus area for Vaisala's Controlled Environments business, and the acquisition of Veriteq, with its life science emphasis, aligns with Vaisala's strategy.

"Vaisala is currently known as an instrument provider in the global pharmaceutical market. We want to strengthen our position by expanding our offering both to pharmaceutical and other life science customers. The Veriteq acquisition is a major step towards this goal, bringing additional know-how, a customer base, products and services to Vaisala," says Pirjo Kortteisto, Director of Cleanrooms and Chambers market segment.

Related News

QIMR Berghofer signs strategic partnership with Nakanoshima Qross

QIMR Berghofer and Japanese biomedical innovation hub Nakanoshima Qross have signed a strategic...

Dr Chris Baldwin is new HaemaLogiX CEO and Managing Director

Having commenced in January, Dr Chris Baldwin is clinical stage Australian biotechnology company...

Vaxxas appoints former Merck Global Vaccines President David Peacock as CEO

To lead the commercialisation of Vaxxas's proprietary high‑density microarray patch (HD‑MAP)...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd